196 related articles for article (PubMed ID: 12750176)
61. Influence of bcr-3 PML-RARα transcript on outcome in Acute Promyelocytic Leukemia patients of Kashmir treated with all-trans retinoic acid and/or arsenic tri-oxide.
Baba SM; Shah ZA; Pandith AA; Dil-Afroze ; Jan A; Mir KA; Aziz SA; Ahmad Z
Cancer Genet; 2019 Feb; 231-232():14-21. PubMed ID: 30803552
[TBL] [Abstract][Full Text] [Related]
62. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
[TBL] [Abstract][Full Text] [Related]
63. PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.
Subramanyam D; Belair CD; Barry-Holson KQ; Lin H; Kogan SC; Passegué E; Blelloch R
Cancer Res; 2010 Nov; 70(21):8792-801. PubMed ID: 20861188
[TBL] [Abstract][Full Text] [Related]
64. Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.
Rego EM; Pandolfi PP
Semin Hematol; 2001 Jan; 38(1):54-70. PubMed ID: 11172540
[TBL] [Abstract][Full Text] [Related]
65. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
[TBL] [Abstract][Full Text] [Related]
66. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
[TBL] [Abstract][Full Text] [Related]
67. The theory of APL.
Piazza F; Gurrieri C; Pandolfi PP
Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
[TBL] [Abstract][Full Text] [Related]
68. Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene.
Douer D; Santillana S; Ramezani L; Samanez C; Slovak ML; Lee MS; Watkins K; Williams T; Vallejos C
Br J Haematol; 2003 Aug; 122(4):563-70. PubMed ID: 12899711
[TBL] [Abstract][Full Text] [Related]
69. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.
Kogan SC; Hong SH; Shultz DB; Privalsky ML; Bishop JM
Blood; 2000 Mar; 95(5):1541-50. PubMed ID: 10688806
[TBL] [Abstract][Full Text] [Related]
70. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
71. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
Westervelt P; Pollock JL; Oldfather KM; Walter MJ; Ma MK; Williams A; DiPersio JF; Ley TJ
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9468-73. PubMed ID: 12077315
[TBL] [Abstract][Full Text] [Related]
72. Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.
Puccetti E; Ruthardt M
Leukemia; 2004 Jul; 18(7):1169-75. PubMed ID: 15103387
[TBL] [Abstract][Full Text] [Related]
73. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
74. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract][Full Text] [Related]
75. Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.
Tobal K; Moore H; Macheta M; Yin JA
Leukemia; 2001 Jul; 15(7):1060-5. PubMed ID: 11455974
[TBL] [Abstract][Full Text] [Related]
76. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract][Full Text] [Related]
77. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.
Voisset E; Moravcsik E; Stratford EW; Jaye A; Palgrave CJ; Hills RK; Salomoni P; Kogan SC; Solomon E; Grimwade D
Blood; 2018 Feb; 131(6):636-648. PubMed ID: 29191918
[TBL] [Abstract][Full Text] [Related]
78. The PML domain of PML-RARα blocks senescence to promote leukemia.
Korf K; Wodrich H; Haschke A; Ocampo C; Harder L; Gieseke F; Pollmann A; Dierck K; Prall S; Staege H; Ma H; Horstmann MA; Evans RM; Sternsdorf T
Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12133-8. PubMed ID: 25092303
[TBL] [Abstract][Full Text] [Related]
79. Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.
Chan IT; Kutok JL; Williams IR; Cohen S; Moore S; Shigematsu H; Ley TJ; Akashi K; Le Beau MM; Gilliland DG
Blood; 2006 Sep; 108(5):1708-15. PubMed ID: 16675706
[TBL] [Abstract][Full Text] [Related]
80. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.
Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K
PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]